Balyasny Asset Management »

Jazz Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $19M 346k 55.91
2012-12-31 $10M 195k 53.25
2012-06-30 $1.4M 30k 45.03

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Dimensional Fund Advisors
Capital World Investors
LSV Asset Management
State Street Corporation
Jpmorgan Chase & Co
Ameriprise Financial
EcoR1 Capital
Hanna Zanoni
Geode Capital Management
GoldenTree Asset Management
Swedbank AB
Morgan Stanley
Citadel Advisors

View all funds holding Jazz Pharmaceuticals